Massachusetts Wealth Management Sells 250 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Massachusetts Wealth Management reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 35.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 457 shares of the healthcare conglomerate’s stock after selling 250 shares during the period. Massachusetts Wealth Management’s holdings in UnitedHealth Group were worth $226,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of UNH. Vanguard Group Inc. grew its stake in UnitedHealth Group by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock valued at $44,150,045,000 after purchasing an additional 250,291 shares in the last quarter. Wellington Management Group LLP raised its position in UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares in the last quarter. Capital Research Global Investors grew its position in shares of UnitedHealth Group by 2.2% in the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after acquiring an additional 324,733 shares during the period. Capital International Investors raised its holdings in shares of UnitedHealth Group by 4.8% in the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after purchasing an additional 542,424 shares during the period. Finally, Norges Bank bought a new position in UnitedHealth Group during the fourth quarter worth about $5,802,231,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

NYSE:UNH traded down $8.35 during mid-day trading on Thursday, reaching $489.89. The stock had a trading volume of 2,239,210 shares, compared to its average volume of 4,580,982. The stock has a 50-day simple moving average of $498.64 and a two-hundred day simple moving average of $501.12. The stock has a market capitalization of $450.89 billion, a PE ratio of 29.94, a P/E/G ratio of 1.47 and a beta of 0.60. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the prior year, the company earned $6.26 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date of this dividend was Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is presently 51.34%.

Wall Street Analyst Weigh In

UNH has been the subject of several research analyst reports. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 target price for the company in a research note on Wednesday, June 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, June 12th. Truist Financial restated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. TD Cowen dropped their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Finally, Morgan Stanley lowered their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.